NO942919L - Fenylalaninanaloger av bombesin - Google Patents

Fenylalaninanaloger av bombesin

Info

Publication number
NO942919L
NO942919L NO942919A NO942919A NO942919L NO 942919 L NO942919 L NO 942919L NO 942919 A NO942919 A NO 942919A NO 942919 A NO942919 A NO 942919A NO 942919 L NO942919 L NO 942919L
Authority
NO
Norway
Prior art keywords
bombesin
derivatives
phenylalanine analogues
tests
antagonizing
Prior art date
Application number
NO942919A
Other languages
English (en)
Norwegian (no)
Other versions
NO942919D0 (en, 2012
Inventor
Judson Vincent Edwards
Bradford Otto Fanger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO942919D0 publication Critical patent/NO942919D0/no
Publication of NO942919L publication Critical patent/NO942919L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57572Gastrin releasing peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO942919A 1992-02-07 1994-08-05 Fenylalaninanaloger av bombesin NO942919L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83383492A 1992-02-07 1992-02-07
PCT/US1993/000183 WO1993016105A1 (en) 1992-02-07 1993-01-07 Phenylalanine analogs of bombesin

Publications (2)

Publication Number Publication Date
NO942919D0 NO942919D0 (en, 2012) 1994-08-05
NO942919L true NO942919L (no) 1994-08-05

Family

ID=25265391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942919A NO942919L (no) 1992-02-07 1994-08-05 Fenylalaninanaloger av bombesin

Country Status (14)

Country Link
US (1) US5428018A (en, 2012)
EP (1) EP0626973A1 (en, 2012)
JP (1) JPH07505865A (en, 2012)
KR (1) KR950700325A (en, 2012)
AU (1) AU668909B2 (en, 2012)
CA (1) CA2129032A1 (en, 2012)
FI (1) FI943638L (en, 2012)
HU (1) HUT71585A (en, 2012)
IL (1) IL104621A0 (en, 2012)
MX (1) MX9300602A (en, 2012)
NO (1) NO942919L (en, 2012)
NZ (1) NZ246815A (en, 2012)
WO (1) WO1993016105A1 (en, 2012)
ZA (1) ZA93716B (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US7078413B2 (en) 1996-04-19 2006-07-18 Wisconsin Alumni Research Foundation Compositions and methods of use for a bombesin peptide
UA65549C2 (uk) 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
CA2283854A1 (en) * 1997-04-22 1998-10-29 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
JP4610345B2 (ja) * 2003-01-13 2011-01-12 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 医薬品化合物のための改善されたリンカー
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) * 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
AU2013323596C1 (en) 2012-09-25 2020-10-15 Advanced Accelerator Applications International Sa GRPR-antagonists for detection, diagnosis and treatment of GRPR-positive cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
US4631270A (en) * 1978-11-20 1986-12-23 Research Corporation Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
ATE16495T1 (de) * 1981-06-22 1985-11-15 Ici Plc Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
EP0313158A3 (en) * 1987-10-23 1990-08-22 Merck & Co. Inc. Gastrin releasing peptide antagonist
US5047502A (en) * 1987-10-23 1991-09-10 Merck And Co., Inc. Gastrin releasing peptide antagonist
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8806644D0 (en) * 1988-03-21 1988-04-20 Imp Cancer Res Tech Neuropeptide antagonists
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
JP2919889B2 (ja) * 1988-10-14 1999-07-19 アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド 治療用ペプチド
US5028692A (en) * 1989-04-25 1991-07-02 Merck & Co., Inc. Gastrin releasing peptide antagonist
JPH04502629A (ja) * 1989-11-06 1992-05-14 フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ 還元不可逆性ボンベシンアンタゴニスト
NZ236114A (en) * 1989-11-22 1993-04-28 Merrell Dow Pharma Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions
HUT62604A (en) * 1990-05-09 1993-05-28 Univ Tulane Process for producing peptides for treating tissue proliferation and pharmaceutical compositions comprising same
ZA915740B (en) * 1990-07-26 1992-05-27 Merrell Dow Pharma Peptides
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists

Also Published As

Publication number Publication date
JPH07505865A (ja) 1995-06-29
ZA93716B (en) 1993-09-01
KR950700325A (ko) 1995-01-16
FI943638A7 (fi) 1994-08-05
WO1993016105A1 (en) 1993-08-19
AU3439993A (en) 1993-09-03
CA2129032A1 (en) 1993-08-19
MX9300602A (es) 1993-08-01
EP0626973A1 (en) 1994-12-07
NO942919D0 (en, 2012) 1994-08-05
FI943638A0 (fi) 1994-08-05
AU668909B2 (en) 1996-05-23
HU9402285D0 (en) 1994-10-28
NZ246815A (en) 1996-02-27
FI943638L (fi) 1994-08-05
HUT71585A (en) 1995-12-28
IL104621A0 (en) 1993-06-10
US5428018A (en) 1995-06-27

Similar Documents

Publication Publication Date Title
NO942919L (no) Fenylalaninanaloger av bombesin
Marasco et al. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil
Solomon et al. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33
Tashjian Jr et al. Role of calcium in the thyrotropin-releasing hormone-stimulated release of prolactin from pituitary cells in culture
Civitelli et al. Parathyroid hormone-related peptide transiently increases cytosolic calcium in osteoblast-like cells: comparison with parathyroid hormone
ATE156492T1 (de) Bombesinanaloge
US5717062A (en) Cyclic analogs of PTH and PTHrP
Cholewinski et al. Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide
JP2007302682A (ja) 副甲状腺ホルモンの類似体
RU2203286C2 (ru) Аналоги паратиреоидного гормона для лечения остеопороза
NO20051804L (no) GHRH analoger
SE8802569D0 (sv) Improvements in or relation to somatostatins
WO2001054771A3 (en) Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
Ishibashi et al. Inhibition of growth of human small cell lung cancer by bromocriptine
Mizrahi et al. Substance P antagonists active in vitro and in vivo
Vigna et al. Effects of cholecystokinin, gastrin, and related peptides on coho salmon gallbladder contraction in vitro.
Musso et al. Renal vasodilation and microvessel adenylate cyclase stimulation by synthetic parathyroid hormone-like protein fragments
Löffler et al. Parathyrin and calcitonin stimulate cyclic AMP accumulation in cultured murine brain cells.
NO941151L (no) Lineære adhesjonsinhibitorer
Muneoka et al. Pharmacology of FMRFamide in Mytilus catch muscle
Huang et al. Parathyroid hormone stimulates adenylate cyclase in rat cerebral microvessels
Vigna Evolution of endocrine regulation of gastrointestinal function in lower vertebrates
Liang et al. Substance P stimulation of amylase release by isolated parotid cells and inhibition of substance P induction of salivation by vasoactive peptides
McGeachie et al. Reaction of skeletal muscle to small implants of titanium or stainless steel: a quantitative histological and autoradiographic study
Stewart et al. Bradykinin antagonists as new drugs for prostate cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application